Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 30193265.
- Also identified by DOI 10.1001/jama.2018.9014 and PMC identifier 6142991.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study uses Medicare part B billing data to compare trends in the use of filgrastim and its biosimilars among beneficiaries between 2014 and 2016.
Medical subject headings
- Biosimilar Pharmaceuticals
- Drug Utilization
- Filgrastim
- Hematologic Agents